Mirena Observational Program

Mirena is used for long-term in Kazakhstan, and in our observational program we would like to study patients distribution per indications of Mirena, and also patient compliance within a year after Mirena insertion. For patients with all approved indications for Mirena use: contraception, treatment of menorrhagia and protection from endometrial hyperplasia during estrogen replacement therapy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Contraception Endometrial Hyperplasia Estrogen Replacement Therapy Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Hemorrhage Menorrhagia Menstruation Disturbances Pathologic Processes Pathological Conditions, Signs and Symptoms Urogenital Diseases Uterine Diseases Uterine Hemorrhage

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Many Locations, Kazakhstan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients older than 18 years with previously taken decision of their gynecologist to insert Mirena according to registered indications

Exclusion criteria

All patients with contraindications to Mirena insertion, according to approved prescribing information.

Treatment and study plan

Levonorgestrel (Mirena, BAY86-5028)

Drug

Patients older than 18 years with previously taken decision of their gynecologist to insert Mirena according to registered indications

Primary outcomes

Patient distribution per indication

Time frame: 12 months

Secondary outcomes

Patient compliance

Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Registry information

Important dates

Study start: 2009
Primary completion: 2014
Study completion: 2015
First posted: Apr 20, 2009
Registry last updated: Sep 30, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed